Suhagra
Suhagra

1.4
A clinical formulation indicated for Erectile Dysfunction. It supports increased blood flow to targeted regions to facilitate natural physical response.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Sildenafil Citrate
Product Origin
Generic Brand
Product Manufacturer
Cipla Ltd
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Men's Health
Product Category
PDE5 Inhibitor
Pharmacological Class
Phosphodiesterase type 5 (PDE5) inhibitor
Manufacturer Description
A PDE5 inhibitor developed to relieve erectile dysfunction by supporting blood flow to the penis to manage achieving an erection during sexual stimulation.
Mechanism of Action
It works by inhibiting the PDE5 enzyme, which increases levels of a chemical that relaxes smooth muscles in the penis. This allows for increased blood flow during sexual arousal, facilitating a firm erection.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
4–6 hours
Contraindications
Concurrent use of nitrates, Severe heart disease, Recent stroke or heart attack, Allergy to sildenafil
Severe Adverse Events
Priapism (prolonged, painful erection), Sudden hearing loss, Sudden vision loss, Chest pain
Common Side Effects
Headache, Flushing, Indigestion, Nasal congestion, Mild vision changes
Uncommon Side Effects
Dizziness, Back pain, Muscle aches
Drug Interactions
Nitrates, Alpha-blockers, Ketoconazole, Erythromycin, Ritonavir
Pregnancy Safety Warnings
Not applicable.
Age Restrictions
For adult males only.
Storage Guidelines
Store below 30°C in a dry place, protected from light.
Related Products
Information for Suhagra is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories